Companies · Other Health Care
Irvine · Other Health Care
Diligence memoA one-page analyst read on Vesta Medical LLC d/b/a Vestara — recommendation, valuation, rhythm, risks.→Vesta Medical LLC d/b/a Vestara looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Vesta Medical LLC d/b/a Vestara behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Vesta Medical LLC d/b/a Vestara is one of 5377 Other Health Care companies tracked from Irvine. By capital raised it ranks in the upper tier (ahead of 84% of sector peers), and in the upper tier by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 84% of sector peers (real $). Modeled value above 83% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #24 of 48.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Dynova Laboratories Inc | Series A | $26.0M | $302.7M | 2.42× |
| Vocollect Inc | Series A | $15.0M | $302.7M | 2.42× |
| Salient Surgical Technologies, Inc. | Series A | $18.4M | $302.7M | 2.42× |
| Orthohelix Surgical Design Inc | Series A | $23.4M | $283.2M | 2.26× |
| CardioPolymers, Inc. | Series A | $13.6M | $273.9M | 2.19× |
| Natural Dentist Inc | Series A | $12.6M | $255.1M | 2.04× |
| Granite Investment Group | Series A | $12.5M | $252.2M | 2.02× |
| Portaero, Inc | Series A | $11.8M | $238.5M | 1.91× |
| Prematics Inc | Series A | $10.8M | $217.7M | 1.74× |
| Replenish, Inc. | Series A | $10.2M | $206.8M | 1.65× |
| Wellsense Technologies LLC | Series A | $9.2M | $185.0M | 1.48× |
| Docusys Inc | Series A | $8.8M | $178.4M | 1.43× |
| Vesta Medical LLC d/b/a Vestara this company | Series A | $19.6M | $125.6M | 1.00× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $6.2M | 2009-05-15 | $28.3M | $125.6M | 90% |
| Series A | $4.0M | 2009-05-15 | $18.4M | $81.5M | 90% |
| Seed | $3.4M | 2009-05-15 | $16.8M | $83.2M | 90% |
| Seed | $2.9M | 2009-05-15 | $14.7M | $72.6M | 90% |
| Seed | $2.1M | 2009-05-15 | $10.6M | $52.4M | 90% |
| Pre-Seed | $890K | 2009-05-15 | $4.9M | $27.4M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Robert Morris | — | 6 other | 2009-05 |
| Arthur Bertolero | — | 4 other | 2009-05 |
| William E. Maya | — | 3 other | 2009-05 |
| Alan Davidner | — | 2 other | 2009-05 |
| John K Stroh | — | 1 other | 2009-05 |
| Michael J Greer | — | 1 other | 2009-05 |
| Michael J Martin | — | 1 other | 2009-05 |
| Alan E Davidner | — | — | 2009-05 |
| Arthur K Bertolero | — | — | 2009-05 |
| Arthur R Bertolero | — | — | 2009-05 |
| Robert J Morris | — | — | 2009-05 |
| Scott R Mallett | — | — | 2009-05 |
Vesta Medical LLC d/b/a Vestara is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Neomatrix Llc | Other Health Care | Series A | $12.0M | $85.3M | network5 shared operators · same sector · same stage |
| ExsoMed Corp | Other Health Care | Series A | $15.7M | $180.0M | network1 shared operator · same sector · same stage |
| Endoclear LLC | Other Health Care | Seed | $6.4M | $19.4M | network2 shared operators · same sector |
| Akshay Wellness, Inc. | Other Health Care | Series A | $19.8M | $126.9M | same sector · same stage |
| Cayenne Medical Inc | Other Health Care | Series A | $19.8M | $100.9M | same sector · same stage |
| SmartyPants, Inc. | Other Health Care | Series A | $19.3M | $136.0M | same sector · same stage |
| Informed Medical Decisions, Inc. | Other Health Care | Series A | $19.2M | $131.2M | same sector · same stage |
| Insightra Medical, Inc. | Other Health Care | Series A | $20.0M | $100.9M | same sector · same stage |
See where Vesta Medical LLC d/b/a Vestara sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Vesta Medical LLC d/b/a Vestara, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.